BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 7542107)

  • 1. The interaction of cytokines with human basophils and mast cells.
    Schroeder JT; Kagey-Sobotka A; MacGlashan DW; Lichtenstein LM
    Int Arch Allergy Immunol; 1995; 107(1-3):79-81. PubMed ID: 7542107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omalizumab may not inhibit mast cell and basophil activation in vitro.
    Gericke J; Ohanyan T; Church MK; Maurer M; Metz M
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1832-6. PubMed ID: 25257818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of human basophils and mast cells in allergic disorders.
    Marone G; Casolaro V; Cirillo R; Stellato C; Genovese A
    Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 2):S24-40. PubMed ID: 2463127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human mast cells and basophils-How are they similar how are they different?
    Varricchi G; Raap U; Rivellese F; Marone G; Gibbs BF
    Immunol Rev; 2018 Mar; 282(1):8-34. PubMed ID: 29431214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bispecific antibody against human IgE and human FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils.
    Tam SW; Demissie S; Thomas D; Daƫron M
    Allergy; 2004 Jul; 59(7):772-80. PubMed ID: 15180766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5. IgE, mast cells, basophils, and eosinophils.
    Prussin C; Metcalfe DD
    J Allergy Clin Immunol; 2006 Feb; 117(2 Suppl Mini-Primer):S450-6. PubMed ID: 16455345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical constituents of diesel exhaust particles induce IL-4 production and histamine release by human basophils.
    Devouassoux G; Saxon A; Metcalfe DD; Prussin C; Colomb MG; Brambilla C; Diaz-Sanchez D
    J Allergy Clin Immunol; 2002 May; 109(5):847-53. PubMed ID: 11994710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of basophils in allergic disease.
    Knol EF; Mul FP; Lie WJ; Verhoeven AJ; Roos D
    Eur Respir J Suppl; 1996 Aug; 22():126s-131s. PubMed ID: 8871057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine-releasing factor/translationally controlled tumor protein (HRF/TCTP)-induced histamine release is enhanced with SHIP-1 knockdown in cultured human mast cell and basophil models.
    Langdon JM; Schroeder JT; Vonakis BM; Bieneman AP; Chichester K; Macdonald SM
    J Leukoc Biol; 2008 Oct; 84(4):1151-8. PubMed ID: 18625911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
    Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
    Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of integrin clustering on human lung mast cells and basophils.
    Lavens SE; Goldring K; Thomas LH; Warner JA
    Am J Respir Cell Mol Biol; 1996 Jan; 14(1):95-103. PubMed ID: 8534491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and cellular biology of mast cells and basophils.
    Marone G; Casolaro V; Patella V; Florio G; Triggiani M
    Int Arch Allergy Immunol; 1997 Nov; 114(3):207-17. PubMed ID: 9363900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basophil-mast cell response syndromes: a unified clinical approach.
    Patterson R; Pruzansky JJ; Dykewicz MS; Lawrence ID
    Allergy Proc; 1988; 9(6):611-20. PubMed ID: 3066689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of mast cells, basophils and their mediators in adverse reactions to general anesthetics and radiocontrast media.
    Genovese A; Stellato C; Marsella CV; Adt M; Marone G
    Int Arch Allergy Immunol; 1996 May; 110(1):13-22. PubMed ID: 8645973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histamine Release from Mast Cells and Basophils.
    Borriello F; Iannone R; Marone G
    Handb Exp Pharmacol; 2017; 241():121-139. PubMed ID: 28332048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
    Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
    J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of signal transduction mechanisms in human basophils and human skin mast cells. II. Effects of 7-O-methyl-UCN-01, NPC 15437 and bryostatin 1 and 2, four protein kinase C-modulatory agents, on mediator release.
    Noll T; Dieckmann D; Gibbs BF; Nitschke M; Albrecht C; Vollrath I; Tamaoki T; Wolff HH; Amon U
    Biol Signals; 1997; 6(1):1-10. PubMed ID: 9098518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemokines and the histamine-releasing factors: modulation of function of basophils, mast cells and eosinophils.
    Alam R; Grant JA
    Chem Immunol; 1995; 61():148-60. PubMed ID: 7544980
    [No Abstract]   [Full Text] [Related]  

  • 19. Histamine-releasing factors and inhibitors: historical perspectives and possible implications in human illness.
    Grant JA; Alam R; Lett-Brown MA
    J Allergy Clin Immunol; 1991 Nov; 88(5):683-93. PubMed ID: 1720148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of mast-cell and basophil function and survival by IgE.
    Kawakami T; Galli SJ
    Nat Rev Immunol; 2002 Oct; 2(10):773-86. PubMed ID: 12360215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.